IL115293A - Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same - Google Patents
Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the sameInfo
- Publication number
- IL115293A IL115293A IL11529395A IL11529395A IL115293A IL 115293 A IL115293 A IL 115293A IL 11529395 A IL11529395 A IL 11529395A IL 11529395 A IL11529395 A IL 11529395A IL 115293 A IL115293 A IL 115293A
- Authority
- IL
- Israel
- Prior art keywords
- inflammatory factor
- purification
- pharmaceutical compositions
- compositions containing
- same
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000005166 vasculature Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/316,474 US5650175A (en) | 1982-06-03 | 1994-10-03 | Anti-inflammatory factor, method of isolation, and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115293A0 IL115293A0 (en) | 1995-12-31 |
| IL115293A true IL115293A (en) | 2000-12-06 |
Family
ID=23229212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11529395A IL115293A (en) | 1994-10-03 | 1995-09-14 | Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5650175A (zh) |
| EP (1) | EP0787007B1 (zh) |
| JP (2) | JP4234197B2 (zh) |
| KR (1) | KR100424403B1 (zh) |
| AT (1) | ATE211916T1 (zh) |
| AU (1) | AU692608B2 (zh) |
| CA (1) | CA2201106C (zh) |
| DE (1) | DE69525060T2 (zh) |
| DK (1) | DK0787007T3 (zh) |
| ES (1) | ES2170809T3 (zh) |
| FI (1) | FI120574B (zh) |
| HK (1) | HK1000552A1 (zh) |
| IL (1) | IL115293A (zh) |
| MX (1) | MX9702398A (zh) |
| NO (1) | NO318921B1 (zh) |
| NZ (2) | NZ293763A (zh) |
| PT (1) | PT787007E (zh) |
| TW (1) | TW410157B (zh) |
| WO (1) | WO1996010410A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980953A (en) * | 1994-10-03 | 1999-11-09 | Stolle Milk Biologics, Inc. | Anti-inflammatory factor, method of isolation, and use |
| JP2001342127A (ja) * | 2000-06-02 | 2001-12-11 | Nomoto Kikuo | 腸吸収性抗炎症因子含有免疫性物質及びその応用 |
| US6770280B1 (en) | 2001-11-15 | 2004-08-03 | Humanetics Corporation | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
| US20110183052A1 (en) * | 2004-10-07 | 2011-07-28 | Next Proteins, Inc. | Protein beverage and method of making the same |
| US9220292B2 (en) | 2004-10-07 | 2015-12-29 | Next Problems, Inc. | Protein beverage and method of making same |
| US20080206415A1 (en) * | 2004-10-07 | 2008-08-28 | Next Proteins, Inc. | Protein beverage and method of making the same |
| US20070025980A1 (en) * | 2005-07-27 | 2007-02-01 | Krogsgaard David L | Composition permitting muscle growth while protecting joint health |
| US20080026983A1 (en) * | 2006-07-28 | 2008-01-31 | Gardiner Paul T | Compositions and methods for alleviating joint pain and improving joint flexibility |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
| US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
| GB1211876A (en) * | 1967-11-23 | 1970-11-11 | Twyford Lab Ltd | Improvements in and relating to prophylactic and therapeutic preparations |
| CH590064A5 (zh) * | 1973-11-28 | 1977-07-29 | Biokema Sa | |
| US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
| US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
| US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
| ATE16349T1 (de) * | 1981-04-28 | 1985-11-15 | Stolle Res & Dev | Verfahren zur herstellung einer entzuendungshemmenden rindermilch. |
| US4956349A (en) * | 1983-10-27 | 1990-09-11 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
| US5242691A (en) * | 1982-06-03 | 1993-09-07 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US5352462A (en) * | 1982-06-03 | 1994-10-04 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US4897265A (en) * | 1983-10-27 | 1990-01-30 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
| EP0300102B1 (en) * | 1987-07-21 | 1993-03-24 | The Stolle Research And Development Corporation | Improved method of obtaining immune regulatory factors by mammal immunization |
-
1994
- 1994-10-03 US US08/316,474 patent/US5650175A/en not_active Expired - Lifetime
-
1995
- 1995-09-08 EP EP95933752A patent/EP0787007B1/en not_active Expired - Lifetime
- 1995-09-08 DE DE69525060T patent/DE69525060T2/de not_active Expired - Lifetime
- 1995-09-08 NZ NZ293763A patent/NZ293763A/xx not_active IP Right Cessation
- 1995-09-08 NZ NZ333653A patent/NZ333653A/xx not_active IP Right Cessation
- 1995-09-08 AU AU36282/95A patent/AU692608B2/en not_active Ceased
- 1995-09-08 WO PCT/US1995/011398 patent/WO1996010410A1/en not_active Ceased
- 1995-09-08 HK HK97102084A patent/HK1000552A1/zh not_active IP Right Cessation
- 1995-09-08 DK DK95933752T patent/DK0787007T3/da active
- 1995-09-08 MX MX9702398A patent/MX9702398A/es not_active IP Right Cessation
- 1995-09-08 PT PT95933752T patent/PT787007E/pt unknown
- 1995-09-08 ES ES95933752T patent/ES2170809T3/es not_active Expired - Lifetime
- 1995-09-08 JP JP51179796A patent/JP4234197B2/ja not_active Expired - Fee Related
- 1995-09-08 AT AT95933752T patent/ATE211916T1/de not_active IP Right Cessation
- 1995-09-08 KR KR1019970702176A patent/KR100424403B1/ko not_active Expired - Fee Related
- 1995-09-08 CA CA2201106A patent/CA2201106C/en not_active Expired - Lifetime
- 1995-09-14 IL IL11529395A patent/IL115293A/xx not_active IP Right Cessation
- 1995-10-06 TW TW084110628A patent/TW410157B/zh not_active IP Right Cessation
-
1997
- 1997-03-25 FI FI971245A patent/FI120574B/fi active IP Right Grant
- 1997-04-01 NO NO19971474A patent/NO318921B1/no not_active IP Right Cessation
-
2008
- 2008-02-13 JP JP2008032481A patent/JP2008133299A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR100424403B1 (ko) | 2004-05-20 |
| NO318921B1 (no) | 2005-05-23 |
| NO971474D0 (no) | 1997-04-01 |
| NZ293763A (en) | 1999-02-25 |
| FI120574B (fi) | 2009-12-15 |
| DE69525060D1 (de) | 2002-02-21 |
| CA2201106A1 (en) | 1996-04-11 |
| EP0787007A1 (en) | 1997-08-06 |
| DK0787007T3 (da) | 2002-04-22 |
| PT787007E (pt) | 2002-07-31 |
| CA2201106C (en) | 2010-03-23 |
| AU692608B2 (en) | 1998-06-11 |
| DE69525060T2 (de) | 2002-11-14 |
| ES2170809T3 (es) | 2002-08-16 |
| MX9702398A (es) | 1997-06-28 |
| IL115293A0 (en) | 1995-12-31 |
| TW410157B (en) | 2000-11-01 |
| KR970706008A (ko) | 1997-11-03 |
| US5650175A (en) | 1997-07-22 |
| WO1996010410A1 (en) | 1996-04-11 |
| AU3628295A (en) | 1996-04-26 |
| FI971245A0 (fi) | 1997-03-25 |
| EP0787007B1 (en) | 2002-01-16 |
| JP4234197B2 (ja) | 2009-03-04 |
| NO971474L (no) | 1997-06-03 |
| FI971245L (fi) | 1997-05-28 |
| JP2008133299A (ja) | 2008-06-12 |
| NZ333653A (en) | 2000-08-25 |
| JPH10509420A (ja) | 1998-09-14 |
| ATE211916T1 (de) | 2002-02-15 |
| HK1000552A1 (zh) | 2002-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2123665A3 (en) | Inhibitors of interleukin-1Beta converting enzyme | |
| CA2176494A1 (en) | Purification of Hemoglobin | |
| ATE163043T1 (de) | Reinigungsmethode und entsprechende vorrichtung | |
| UA29421C2 (uk) | Спосіб виділення фактора vііі з інших білків в плазмі крові | |
| CA2254871A1 (en) | Purification of biologically active peptides from milk | |
| ATE240103T1 (de) | Intermediaires des produits definitifs de glycosylation avancee et inhibition des produits age post-amadori | |
| EP0089245A3 (en) | A stable interferon beta composition and a method of stabilizing interferon beta | |
| MX9701183A (es) | Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones. | |
| BG103286A (en) | Compositions and methods for ore dressing | |
| IL115293A (en) | Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same | |
| IL121464A0 (en) | Anti-inflammatory factor and pharmaceutical compositions containing the same | |
| IT1266734B1 (it) | Gruppo per la molatura di lastre di vetro. | |
| ES8404514A1 (es) | Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad | |
| AUPP971399A0 (en) | Separation of plasma components | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| HU9600209D0 (en) | Process for the extaction of periplasmatic proteins from microorganisms in the presence of arginin | |
| MY117908A (en) | Anti-inflammatory factor, method of isolation, and use | |
| CA2029201A1 (en) | Process for purifying b pertussis antigens | |
| EP0731709A4 (en) | INNOVATIVE NEUTROPHILE INHIBITORS | |
| IT1266672B1 (it) | Procedimento per l'isolamento e la purificazione di mevinolina | |
| EP0723454A4 (en) | Novel tripeptides useful in immune and cns therapy | |
| FI952292A7 (fi) | Menetelmä kiinteiden materiaalien erottamiseksi mikro-organismeista | |
| EP0780398A3 (en) | Process for purifying tammhorsfall glycoprotein or uromodulin, their purified products and method for making the discrimination between both of them | |
| MX9805015A (es) | INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta. | |
| GB9510753D0 (en) | Method for the molecular cloning of antigens,which are recognised by cd4+lymphocytes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |